Tweet
Looking at the SNP's in Clinvar, for example http://www.ncbi.nlm.nih.gov/clinvar/variation/11/, I see that the SNP NM_000410.3(HFE):c.193A>T (p.Ser65Cys) (also known as rs1800730) corresponds to the disease hemochromatosis. Since we have 2 alleles, that means the genotype possibilities are AA, AT, or TT. From the ClinVar data, is it possible to see which genotype are associated with the disease? I assume that since we have a A to T mutation, then T must be the pathogenic allele. So, does this mean TT is worse than AT which is worse than AA?
-
Last edited by leontp587; 11-18-2014, 01:37 PM. -
I have the same question. Could anyone can explain?Originally posted by leontp587 View Post -
Hello,
whether AT or TT is needed to be pathogenic depends on the mode of inheritance. Is it dominant than it is enough if one allele has T, if it is recessive you need TT (or a second mutation in the gene on the other allele).
In clinvar you find under "Condition(s)" links to OMIM, where you can read about the inheritance.
fin swimmerComment
-
You may also want to expand the text in "Summary evidence" (on the Illumina and Invitae rows).Comment
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment